Breast Cancer Program
The Breast Cancer Programís mission is clinical-focused basic and population research; translation of results from this research into improvements in diagnosis, prevention, and treatment of human breast cancer; and clinical research concerning treatment, prevention, and diagnosis.
Breast cancer is a heterogeneous disease, so improved outcomes will be the result of tailored approaches to risk factors, prevention, diagnosis, and treatment. To help implement these approaches, the Program fosters communication among DF/HCC investigators through scientific meetings, focused research planning retreats, and electronic and print media. The Program also encourages collaborative research between clinical- and discipline-based programs, among DF/HCC institutions, and among investigators in other NCI-supported Cancer Centers and SPOREs.
The Breast Cancer Program has five specific aims:
- Investigate the pathogenesis of human breast cancer
- Investigate mechanisms of breast cancer progression
- Investigate etiology of and susceptibility to breast cancer
- Improve the treatment of breast cancer
- Improve the delivery of breast healthcare
- Expand the base of collaborative research support
- Promote increased use of shared resources
- Increased communication and interaction among researchers
- Centralized and rationalized clinical trial mechanisms
- Critical Core resources
- Dissemination of critical information to cancer researchers
- Leveraging infrastructures to build and secure additional funding